Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras

Virology

Volumn 356, Issue 1-2, 2006, Pages 68-78

  Berger, Kristi L ^a   Barriga, Felicia ^a   Lace, Michael J ^b   Turek, Lubomir P ^b   Zamba, Gideon J ^c   Domann, Frederick E ^d   Lee, John H ^d   Klingelhutz, Aloysius J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Anchorage independence; Cervical keratinocyte; Episomal HPV; Episome; Extrachromosomal; HPV; Papillomavirus; Ras; Transformation

Indexed keywords

PROTEIN E6; PROTEIN E7; PROTEIN P53;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMOBILIZED CELL; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELL TRANSFORMATION, VIRAL; CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MICE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; RAS PROTEINS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 33750978679     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.039     Document Type: Article

References (69)

1. Alonio L.V., Picconi M.A., Dalbert D., Mural J., Bartt O., Bazan G., Dominguez M., and Teyssie A.R. Ha-ras oncogene mutation associated to progression of papillomavirus induced lesions of uterine cervix. J. Clin. Virol. 27 (2003) 263-269
2. Andersson S., Safari H., Mints M., Lewensohn-Fuchs I., Gyllensten U., and Johansson B. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 92 (2005) 2195-2200
3. Arias-Pulido H., Peyton C.L., Joste N.E., Vargas H., and Wheeler C.M. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 44 (2006) 1755-1762
4. Bernard C., Mougin C., Laurent R., and Lab M. Oncogene activation: an informative marker for the human papillomavirus-lesions severity. Cancer Detect. Prev. 18 (1994) 273-282
5. Bihani T., Mason D.X., Jackson T.J., Chen S.C., Boettner B., and Lin A.W. Differential oncogenic Ras signaling and senescence in tumor cells. Cell Cycle 3 (2004) 1201-1207
6. Blanton R.A., Perez-Reyes N., Merrick D.T., and McDougall J.K. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am. J. Pathol. 138 (1991) 673-685
7. Boehm J.S., Hession M.T., Bulmer S.E., and Hahn W.C. Transformation of human and murine fibroblasts without viral oncoproteins. Mol. Cell. Biol. 25 (2005) 6464-6474
8. Chakrabarti O., Veeraraghavalu K., Tergaonkar V., Liu Y., Androphy E.J., Stanley M.A., and Krishna S. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J. Virol. 78 (2004) 5934-5945
9. Cordova-Alarcon E., Centeno F., Reyes-Esparza J., Garcia-Carranca A., and Garrido E. Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line. Arch. Med. Res. 36 (2005) 311-316
10. DiPaolo J.A., Woodworth C.D., Popescu N.C., Notario V., and Doniger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4 (1989) 395-399
11. Doorbar J., Parton A., Hartley K., Banks L., Crook T., Stanley M., and Crawford L. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178 (1990) 254-262
12. Durst M., Gallahan D., Jay G., and Rhim J.S. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173 (1989) 767-771
13. Durst M., Bosch F.X., Glitz D., Schneider A., and zur Hausen H. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J. Virol. 65 (1991) 796-804
14. Farwell D.G., Shera K.A., Koop J.I., Bonnet G.A., Matthews C.P., Reuther G.W., Coltrera M.D., McDougall J.K., and Klingelhutz A.J. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am. J. Pathol. 156 (2000) 1537-1547
15. Ferbeyre G., de Stanchina E., Lin A.W., Querido E., McCurrach M.E., Hannon G.J., and Lowe S.W. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22 (2002) 3497-3508
16. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., and Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 262 (1999) 344-354
17. Foster S.A., and Galloway D.A. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 12 (1996) 1773-1779
18. Frattini M.G., Lim H.B., and Laimins L.A. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3062-3067
19. Frattini M.G., Lim H.B., Doorbar J., and Laimins L.A. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71 (1997) 7068-7072
20. Gaiotti D., Chung J., Iglesias M., Nees M., Baker P.D., Evans C.H., and Woodworth C.D. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol. Carcinog. 27 (2000) 97-109
21. Gammoh N., Grm H.S., Massimi P., and Banks L. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol. 80 (2006) 1787-1797
22. Giarre M., Caldeira S., Malanchi I., Ciccolini F., Leao M.J., and Tommasino M. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest. J. Virol. 75 (2001) 4705-4712
23. Goessel G., Quante M., Hahn W.C., Harada H., Heeg S., Suliman Y., Doebele M., von Werder A., Fulda C., Nakagawa H., Rustgi A.K., Blum H.E., and Opitz O.G. Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15599-15604
24. Grm H.S., Massimi P., Gammoh N., and Banks L. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24 (2005) 5149-5164
25. Hahn W.C., Dessain S.K., Brooks M.W., King J.E., Elenbaas B., Sabatini D.M., DeCaprio J.A., and Weinberg R.A. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22 (2002) 2111-2123
26. Halbert C.L., Demers G.W., and Galloway D.A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65 (1991) 473-478
27. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
28. Hua V.Y., Wang W.K., and Duesberg P.H. Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9614-9619
29. Hummel M., Hudson J.B., and Laimins L.A. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66 (1992) 6070-6080
30. Jeon S., Allen-Hoffmann B.L., and Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69 (1995) 2989-2997
31. Katz M.E., and McCormick F. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7 (1997) 75-79
32. Klingelhutz A.J., Smith P.P., Garrett L.R., and McDougall J.K. Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human keratinocytes transformed by nitrosomethylurea. Oncogene 8 (1993) 95-99
33. Lanham S., Herbert A., and Watt P. HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients. J. Clin. Pathol. 54 (2001) 304-308
34. Lazarov M., Kubo Y., Cai T., Dajee M., Tarutani M., Lin Q., Fang M., Tao S., Green C.L., and Khavari P.A. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat. Med. 8 (2002) 1105-1114
35. Lee J.H., Yi S.M., Anderson M.E., Berger K.L., Welsh M.J., Klingelhutz A.J., and Ozbun M.A. Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2094-2099
36. Lichtig H., Algrisi M., Botzer L.E., Abadi T., Verbitzky Y., Jackman A., Tommasino M., Zehbe I., and Sherman L. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 350 (2006) 216-227
37. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., and Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12 (1998) 3008-3019
38. Mammas I.N., Zafiropoulos A., and Spandidos D.A. Involvement of the ras genes in female genital tract cancer. Int. J. Oncol. 26 (2005) 1241-1255
39. Mantovani F., and Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20 (2001) 7874-7887
40. Mason D.X., Jackson T.J., and Lin A.W. Molecular signature of oncogenic ras-induced senescence. Oncogene 23 (2004) 9238-9246
41. McLaughlin-Drubin M.E., Wilson S., Mullikin B., Suzich J., and Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology 312 (2003) 1-7
42. Medina-Martinez O., Vallejo V., Guido M.C., and Garcia-Carranca A. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Mol. Carcinog. 19 (1997) 83-90
43. Meyers C., Mayer T.J., and Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71 (1997) 7381-7386
44. Miranda E.I., Santana C., Rojas E., Hernandez S., Ostrosky-Wegman P., and Garcia-Carranca A. Induced mitotic death of HeLa cells by abnormal expression of c-H-ras. Mutat. Res. 349 (1996) 173-182
45. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., White M.A., Wright W.E., and Shay J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21 (1999) 115-118
46. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., and Zacny V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 (2001) 7888-7898
47. Ngan H.Y., Liu S.S., Yu H., Liu K.L., and Cheung A.N. Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia. Eur. J. Cancer 35 (1999) 1546-1550
48. Nicke B., Bastien J., Khanna S.J., Warne P.H., Cowling V., Cook S.J., Peters G., Delpuech O., Schulze A., Berns K., Mullenders J., Beijersbergen R.L., Bernards R., Ganesan T.S., Downward J., and Hancock D.C. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell. 20 (2005) 673-685
49. O'Leary J.J., Landers R.J., Silva I., Uhlmann V., Crowley M., Healy I., and Luttich K. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix. J. Clin. Pathol. 51 (1998) 576-582
50. Pett M.R., Herdman M.T., Palmer R.D., Yeo G.S., Shivji M.K., Stanley M.A., and Coleman N. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 3822-3827
51. Pim D., Massimi P., and Banks L. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 15 (1997) 257-264
52. Pinion S.B., Kennedy J.H., Miller R.W., and MacLean A.B. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix. Lancet 337 (1991) 819-820
53. Rhim J.S., Webber M.M., Bello D., Lee M.S., Arnstein P., Chen L.S., and Jay G. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11874-11878
54. Riou G., Barrois M., Sheng Z.M., Duvillard P., and Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 3 (1988) 329-333
55. Romanczuk H., and Howley P.M. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3159-3163
56. Sagae S., Kudo R., Kuzumaki N., Hisada T., Mugikura Y., Nihei T., Takeda T., and Hashimoto M. Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix. Cancer 66 (1990) 295-301
57. Schreiber K., Cannon R.E., Karrison T., Beck-Engeser G., Huo D., Tennant R.W., Jensen H., Kast W.M., Krausz T., Meredith S.C., Chen L., and Schreiber H. Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene 23 (2004) 3972-3979
58. Sedman S.A., Barbosa M.S., Vass W.C., Hubbert N.L., Haas J.A., Lowy D.R., and Schiller J.T. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65 (1991) 4860-4866
59. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
60. Skinner J., Bounacer A., Bond J.A., Haughton M.F., deMicco C., and Wynford-Thomas D. Opposing effects of mutant ras oncoprotein on human fibroblast and epithelial cell proliferation: implications for models of human tumorigenesis. Oncogene 23 (2004) 5994-5999
61. Spandidos D.A., Dokianakis D.N., Kallergi G., and Aggelakis E. Molecular basis of gynecological cancer. Ann. N. Y. Acad. Sci. 900 (2000) 56-64
62. Sprague D.L., Phillips S.L., Mitchell C.J., Berger K.L., Lace M., Turek L.P., and Klingelhutz A.J. Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology 301 (2002) 247-254
63. Stanley M.A., Browne H.M., Appleby M., and Minson A.C. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43 (1989) 672-676
64. Takaoka M., Harada H., Deramaudt T.B., Oyama K., Andl C.D., Johnstone C.N., Rhoades B., Enders G.H., Opitz O.G., and Nakagawa H. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction. Oncogene 23 (2004) 6760-6768
65. Thomas J.T., Oh S.T., Terhune S.S., and Laimins L.A. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J. Virol. 75 (2001) 7564-7571
66. Uren A., Fallen S., Yuan H., Usubutun A., Kucukali T., Schlegel R., and Toretsky J.A. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res. 65 (2005) 6199-6206
67. Van Le L., Stoerker J., Rinehart C.A., and Fowler W.C. H-ras codon 12 mutation in cervical dysplasia. Gynecol. Oncol. 49 (1993) 181-184
68. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
69. Zehbe I., Wilander E., Delius H., and Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58 (1998) 829-833